About OpSens

Fiber optic sensors manufacturer offering solutions for interventional cardiology Fractional Flow Reserve FFR, Oil and Gas and industrial applications.

Board of Directors

President, Chief Executive Officer / Louis Laflamme

Louis Laflamme became President, Chief Executive Officer and Director of Opsens in January 2013. He had been Chief Financial Officer and Corporate Secretary of the Company from November 2005 to January 2013. His main tasks are to define and execute the Company’s strategy both toward shareholders and the financial community in operational administrative activities. From March 2005 to November 2005, he was Director, Finance and Administration for DEQ Systems Corp. (TSXV:DEQ), a company manufacturing and distributing electronic systems for tables gambling. From 2002 to 2005, Mr. Laflamme held various positions within the administration department including that of Vice President Finance at TGN biotech inc., a company specializing in research and development in biotechnology. From January 2002 to July 2002, Mr. Laflamme also served as Corporate Controller at St-Raymond Forest Products Ltd., a company involved in the manufacturing of wood veneer. From 1998 to 2001, he was Chief of Mission in the department certification consulting for Samson Bélair / Deloitte & Touche LLP. Mr. Laflamme is a member of Quebec\’s Order of Chartered Professional Accountants since 2001. He received a BA in Business Administration from Université Laval in 1998.

President Opsens Solutions / Gaétan Duplain

Gaétan Duplain has been President of Opsens Solutions since October 2006. His primary responsibilities are to oversee the energy sector’s research activities by orienting the main lines of commercial and intellectual property development, planning the work and implementing the Corporation’s action plan. In 1994, he co-founded FISO Technologies Inc., a company manufacturing fiber optic sensors, where acted as Vice-President from 1994 to 2003. With this company, Mr. Duplain acquired experience in high-tech business development and strategic planning. He obtained a Bachelor’s degree in Physical Engineering from Université Laval in 1985 and a Master’s degree in Optics and Laser from the same university in 1986.

Executive Chairman of the Board / Alan Milinazzo

Mr. Alan Milinazzo is a partner in Heidrick & Struggles’ Boston office and a member of the global Healthcare and Life Sciences Practice, specializing in the medical device sector.

Prior to joining Heidrick & Struggles, Mr. Milinazzo was chief executive officer of InspireMD, a pioneer in embolic prevention systems (EPS) for coronary and vascular applications. He previously served as president and chief executive officer of Orthofix International N.V., a $600 million publicly traded global orthopedic and spine company, and as general manager of Medtronic, Inc.’s coronary and peripheral vascular businesses, where he was instrumental in the development and commercialization of several key products including the company’s first coronary drug-coated stent platform, Endeavor.

Mr. Milinazzo also spent 12 years with Boston Scientific in multiple global sales and marketing leadership roles during a period of unprecedented top line growth in the cardiology franchise.

Mr. Milinazzo currently serves as the executive chair of OpSens (TSX OPSS) and director and chair of the Compensation Committee of Flexion Therapeutics (Nasdaq: FLXN). Prior directorships include CasMed (Nasdaq CASM, acquired by Edwards Life Science), Nasdaq LDR Spine (Nasdaq LDRH acquired by Zimmer-Biomet), Medpace (acquired by PE sponsor Cinven), HET Systems (acquired by Covidien), LumenR (acquired by Boston Scientific), and The Musculoskeletal Transplant Foundation (MTF).

He earned a bachelor’s degree, cum laude, from Boston College. While in college, he interned at the White House, the US House of Representatives, and the John F. Kennedy Library.

Director / Lori Chmura

Lori Chmura brings more than 20 years of experience in the medical device industry. She is currently President and Chief Executive Officer of Soundbite, a privately-held medical device company dedicated to developing clinically relevant and innovative solutions, enabled by their proprietary shock wave technology platform, for the interventional treatment of challenging coronary and peripheral arterial diseases burdened by calcium. Prior to Soundbite, Mrs. Chmura led Dune Medical, a privately held company in the women’s health space, as the Chief Executive Officer, exiting in April of 2020.

Mrs. Chmura began her career as a Critical Care Registered Nurse (CCRN), working in critical care, trauma, and emergency medicine at Yale New Haven Hospital, Emory University Hospital, and St Joseph’s of Atlanta. She transitioned into the medical device industry and has held numerous leadership roles within several blue-chip medical device companies, including Medtronic, Covidien and Johnson and Johnson.

Highly regarded within the industry, Mrs. Chmura is a champion of change management and passionate about delivering growth. She has led numerous Women’s leadership initiatives and currently serves on the ADVAMED Women’s Executive Network Board (WEN) and is Past President-Elect of the Atlanta Chapter board for the Healthcare Businesswomen’s Association. She holds a BSN from Southern Connecticut State University.

Director / Denis Harrington

Mr. Denis Harrington is the owner of Denis L Harrington Consulting, LLC a management and strategy consulting firm he established in 2012 after nearly 30 years of successful leadership roles in the US Army and the Medical Device Industry.

Mr. Harrington presently serves as an Executive Consultant and Board Director for several medical device companies. He has previously served as CEO for BridgePoint Medical and NexGen Medical, successfully leading BridgePoint from its development stage through commercialization and to successful acquisition by Boston Scientific in October, 2012. Denis came to BridgePoint Medical from Boston Scientific where he spent 18 years. His last role at BSC was as Senior Vice-President of US Cardiology, Rhythm and Vascular Sales – managing over 1800 people and $3 billion in revenue.

Denis is a graduate of the United States Military Academy at West Point.

Director / Jean Lavigueur, CA

Jean Lavigueur is, since 2006, Chief Financial Officer of Coveo Solutions Inc., a company working in the field of enterprise search engines. He was, from 2007 to 2012, director of iPerceptions Inc. (TSXV:IPE), a web-focused Customer analytics provider. He was Chairman of iPerceptions Inc.’s Audit Committee and President of the Special Committee of independent directors when the company was sold and privatized. Mr. Lavigueur served on the Board of Cossette Inc. (TSX: KOS) and was responsible for the audit committee and special committee of independent directors until December 2009, when the company was sold and privatized.He was co-founder of Taleo Corporation (NASDAQ:TLEO), a public company providing management services and hiring talent on the Internet and was Chief Financial Officer from 1999 to 2005, after serving for few months, other roles, including Vice President, Finance.From 1996 to 1999, he was Chief Financial Officer of Baan Supply Chain Solutions, a company specializing in the enterprise resource planning (ERP) and from 1991 to 1996, Chief Financial Officer of the Group Berclain inc., a firm specializing in management solutions for assembly lines that had subsequently been acquired by Baan. Prior to joining the Group Berclain inc. Mr. Lavigueur worked within divisions of audit and tax Coopers & Lybrand (now PriceWaterhouseCoopers SRL / LLP), a firm of public accountants. Mr. Lavigueur holds a B.A.A. from Université Laval and has been a certified professional accountant since 1986.

Director / Pat Mackin

Mr. Pat Mackin is President and Chief Executive Officer and Chairman of CryoLife, Inc. (NYSE:CRY) (“CryoLife”) since September 2014, a leader in the manufacturing, processing, and distribution of implantable living tissues and medical devices used in cardiac surgical procedures. CryoLife markets and sells products in more than 80 countries worldwide. Before joining CryoLife, from August 2007 to July 2014, he was President of the Cardiac Rhythm Disease Management Division at Medtronic, Inc. (NYSE:MDT) (“Medtronic”). From 2004 to 2006, also at Medtronic, he held the positions of Vice President, Vascular, Western Europe where he launched the Corporation’s first drug-eluting stent called “Endeavour” and Vice President and General Manager, Endovascular Business Unit. Prior to joining Medtronic, from 1996 to 2002, Mr. Mackin worked for six years at Genzyme, Inc., serving as Senior Vice President and General Manager for the Cardiovascular Surgery Business Unit and as Director of Sales, Surgical Products division. From 1991 to 1996, Mr. Mackin spent five years at Deknatel/Snowden-Pencer, Inc. in various sales and marketing roles and three years as an Officer in the U.S. Army. Mr. Mackin received an MBA from the Kellogg School of Management at Northwestern University and is a graduate of the United States Military Academy at West Point.

Director / Denis Sirois

Denis M. Sirois is President and CEO of Telesystem Energy Ltd. since January 2017, a clean technology company which has developed the world’s most efficient and reliable river hydrokinetic system producing renewable, baseload power.

Mr. Sirois also acts as Vice President – Investments of Telesystem Ltd. since March 2006.  Telesystem Ltd. is a technology focused family office with long-term value creation and innovation as core principals. Telesystem Ltd. has invested over USD1.3B globally in venture opportunities of all stages, and have concluded more than USD22B of transactions since inception.

Denis has over 20 years of experience in corporate finance, mergers and acquisitions and private equity. Through the course of his career, Denis has been involved in transactions of all sizes, ranging from start-ups to multinational corporations.  Mr. Sirois currently sits on the Board of Directors of Telesystem Ltd (and affiliates), Telesystem Energy Ltd, Opsens Inc., Northstar Earth and Space Inc., and journal Le Devoir Inc..